OFAKIM, Israel--(BUSINESS WIRE)--May 12, 2006--Neuroderm Ltd. announced today that it has been granted $490,000 in funding by The Michael J. Fox Foundation for Parkinson's Research. The award will support clinical work to develop a new transdermal skin patch for continuous delivery of levodopa, the natural precursor of dopamine, which is deficient in Parkinson's disease.
